CIC nanoGUNE launches a new call: Industry Collaborative Research Positions
CIC nanoGUNE launches a call —Industry Collaborative Research Positions— which seeks to facilitate the technological development of Basque companies so that they can provide innovative solutions to their industrial challenges thanks to the incorporation of highly qualified researchers.
The purpose of the ICRP program (Industry collaborative research positions) is to facilitate the incorporation of research professionals to local companies, enriching the working teams and making possible to find new approaches to the technological and innovation challenges faced in their production processes. “We are convinced that the key to this is the people”, says Ainara Garcia Gallastegui, TechTransfer director in nanoGUNE.
Research lines in nanoGUNE find applications in sectors as diverse as Health, Energy, Additive Manufacturing, Circular Economy, Automotive Industry, Food, and Quantum Technologies, and contribute to increase the opportunities of local companies to stand out.
Depending on the characteristics of the company, nanoGUNE will offer advice to explore the company’s challenges and identify the profile that best fits its needs and will collaborate in the definition of the individual project for the new incorporation. Besides, the program proposes a joint funding structure to hire the selected candidate.
All the Basque industrial or technology-based companies of all sizes and sectors that would be interested in incorporating to their working teams personnel with a scientific/research profile or that would like to explore the advantages of incorporating this profiles to their staff can do it through nanoGUNE’s website
The deadline for submitting applications is September 30.
The talent you are looking for may be close at hand!
CIC nanoGUNE
The Nanoscience Co-operative Research Center CIC nanoGUNE, located in Donostia/San Sebastian, Basque Country, is a research center set up with the mission to conduct research excellence in nanoscience and nanotechnology with the aim of increasing the Basque Country’s business competitiveness and economic development. NanoGUNE is a member of the Basque Research & Technology Alliance (BRTA) and is also recognized by the National Research Council as a María de Maeztu Unit of Excellence.
Related news
CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors
Taldeki Biosolutions will be developing sensors for rapid, cost-effective, robust antibody detection, thus overcoming the stability and cost problems of current in vitro diagnostics
Basque Open Industry will show Europe its industrial and technological ecosystem at the European SME Week (SME Week) from 13 to 17 November.
Talent, internationalisation, energy-environmental and technology-digital transitions. SME Week 2023. Exhibition and stands at the BEC: “Rebuild Ukraine”.
Aker Solutions selects TUBACEX as a delivery partner for umbilical tubes for key projects on the Norwegian Continental Shelf
An order intake for a sum of more than €70 million is one of the most significant deals in the umbilicals market. Solidifying TUBACEX’s technological position as a supplier of advanced industrial solutions for energy and mobility sectors.
‘Syngoi Technologies’: Columbus VP creates a new company in Bizkaia for synthetic DNA production
Columbus VP, a venture capital investment management company with a singular focus on business opportunities emerging in the biotechnology and life sciences sector.
SPRI Group will propose at the World Manufacturing Forum transformative actions to enhance the presence of women in the manufacturing industry
Cristina Oyón has led the international group of experts that has drafted the report that will be disclosed on October 20th and 21st at the World Manufacturing Forum, which can be followed online for free upon registration
The Basque Government participates in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN
Tapia highlights that, once Harvard advances with the vaccine, the Basque Country is ready to take on this opportunity that represents a unique health, social and business advance
VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)
AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
in 2021 VIVEbiotech will be able to produce lentiviral vectors for advanced clinical trials
VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office
LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells.
Columbus launches a €70 million fund for biomedicine
With the new investment fund, the managers plan to build two new plants in San Sebastian